Palatin Technologies drugs

1 result
  • vyleesi - bremelanotide injection

    (Bremelanotide)
    Palatin Technologies
    Vyleesi treats acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women whose low sexual desire causes marked distress or interpersonal difficulty, and is not attributable to a medical condition, psychiatric condition, relationship issues, or medication effects.